Suppliers / Jewim Pharmaceutical (Shandong)

Jewim Pharmaceutical (Shandong)

China 24 employees Updated 9 July 2026

Jewim Pharmaceutical (Shandong) is an API manufacturer based in China. It holds one active US drug master file. Its filings concentrate with ARCSA (EC), DIGEMAPS (DO) and MINSA (CR). Its GMP standing is certified by INVIMA (CO), NAFDAC (NG) and TMDA (TZ), among 6 authorities. Its most recent recorded inspection, by US FDA, closed on 19 July 2024 as VAI.

1
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
31
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
EU GMP
0 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 19 July 2024 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SHANDONG, China Not on file
China, China 3006452789
Tai-An City - Shandong Province, Colombia Not on file
SHANDONG PROVINCE, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 15 None
DIGEMAPS (DO) 5 None
MINSA (CR) 4 None
NAFDAC (NG) 3 1
UZPHARM (UZ) 3 None
RCETH (BY) 1 None
INVIMA (CO) None 1
TMDA (TZ) None 1
US FDA None 1
ANVISA (Brazil) None 1
EAEU_EEC None 1

Questions about Jewim Pharmaceutical (Shandong)

Does Jewim Pharmaceutical (Shandong) hold a US DMF or a CEP?
Jewim Pharmaceutical (Shandong) holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Jewim Pharmaceutical (Shandong) FDA-registered?
One site operated by Jewim Pharmaceutical (Shandong) carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Jewim Pharmaceutical (Shandong)'s last inspection go?
The most recent inspection on record closed on 19 July 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Jewim Pharmaceutical (Shandong) manufacture?
4 registered sites are on record, in China, Colombia and Nigeria (Shandong, China and Tai-an City - Shandong Province among others). Every site is listed on this page with the register it came from.
What does Jewim Pharmaceutical (Shandong) make?
1 molecule is on record against Jewim Pharmaceutical (Shandong), including Fluvoxamine. Each links through to that molecule's full manufacturer list.
Which regulators recognise Jewim Pharmaceutical (Shandong)'s GMP?
Current GMP certificates are on record from INVIMA (CO), NAFDAC (NG), TMDA (TZ), US FDA, ANVISA (Brazil) and 1 more. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jewim Pharmaceutical (Shandong) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 19 July 2024.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates